Summer fun; but fall blitz wanted

Biotech financing didn't take a summer break, as the sector already has raised more money this quarter than in all of 3Q11. Overall, however, 2012 is still shy of last year's pace.

Biotech has raised $7.8 billion thus far this quarter, which far outstrips the $4.2 billion the industry brought in during 3Q11.It also bests the $7.1 billion raised in 2Q this year (see "Taking Stock"). ...